As part of the Cancer Moonshot, representatives from government, academic, pharmaceutical and diagnostic companies are launching a new partnership in pursuit of creating an open database for liquid biopsies to potentially accelerate the development of safe and effective blood profiling diagnostic technologies for patient benefit.
The University of Michigan Comprehensive Cancer Center is one of 12 sites to joinPrecision Promise, the first large-scale precision medicine trial designed to transform outcomes for patients with pancreatic cancer.
Limiting advanced imaging tests such as CT scans for patients with early stage breast cancer can improve the quality and reduce the cost of care, yet a new University of Michigan Comprehensive Cancer Center study shows many patients still receive such tests despite being at low risk for recurrence.
Outpatient urological surgery costs significantly less when performed in physician offices and ambulatory care centers. But results may reflect the lower cost of treating patients who are less seriously ill.
A new urine test can help aid early detection of and treatment decisions about prostate cancer, a study from the University of Michigan Comprehensive Cancer Center and the Michigan Center for Translational Pathology finds.
Former Michigan football coach Lloyd Carr was honored Saturday night with a surprise gift from long-time athletics donor Al Glick – a gift that will result in the naming of the pediatric cancer unit at the new U-M C.S. Mott Children's Hospital opening this November.